Article Information
History
- March 2, 2021.
Article Versions
- Version 1 (December 4, 2020 - 09:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Martin Pavelka1,2,3,
- Kevin Van-Zandvoort4,5,
- Sam Abbott4,5,
- Katharine Sherratt4,5,
- Marek Majdan7,
- CMMID COVID-19 working group5,
- Inštitút Zdravotných Analýz2,
- Pavol Jarčuška7,
- Marek Krajčí1,+,
- Stefan Flasche4,5,* and
- Sebastian Funk4,5,*
- 1Slovak Ministry of Health, Bratislava, Slovakia
- 2Inštitút Zdravotných Analýz (Institute of Health Analyses), Bratislava, Slovakia
- 3Department of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK
- 4Department for Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
- 5Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK
- 6Institute for Global Health and Epidemiology, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovakia
- 7Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia
- Address correspondence to: Martin Pavelka, Ministerstvo Zdravotníctva, Inštitút Zdravotných Analýz, Limbová 2, Bratislava, 831 01,, Slovensko / Slovakia, martin.pavelka{at}health.gov.sk
↵* authors contributed equally; the order was decided by a coin toss
Posted March 02, 2021.
The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia
